HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Adenosine Monophosphate

HCID 6083
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
136920-07-5
Standard SMILES
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O
InChIKey
UDMBCSSLTHHNCD-KQYNXXCUSA-N
Molecular formula
C10H14N5O7P
Average molar mass
347.22 g/mol
Monoisotopic mass
347.0630848

Overview

Adenosine 5'-monophosphate is a purine ribonucleoside 5'-monophosphate having adenine as the nucleobase. It has a role as a cofactor, a micronutrient, a nutraceutical, an EC 3.1.3.1 (alkaline phosphatase) inhibitor, an EC 3.1.3.11 (fructose-bisphosphatase) inhibitor, an adenosine A1 receptor agonist and a fundamental metabolite. It is a purine ribonucleoside 5'-monophosphate and an adenosine 5'-phosphate. It is a conjugate base of an adenosine 5'-monophosphate(1+). It is a conjugate acid of an adenosine 5'-monophosphate(2-).

Names & identifiers

Preferred name
Adenosine Monophosphate
IUPAC
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
English name
POLYADENYLIC ACID POTASSIUM SALT
Molecular formula
(C10H14N5O7P)x
Molecular weight
347.22

Names & synonyms

adenosine 5'-monophosphate5'-adenylic acidAdenosine monophosphate61-19-8adenosine phosphateCardiomonePhosphentasideAdenoviteadenosine 5'-phosphateLycedanPhosaden5'-AMP
Show more names
5′-Adenylic acid, homopolymerPolyadenylicAcid,M.W.>100,000polyadenylic acid potassium salt mr ~7000000
adenylateMy-B-DenMyostonVitamin B8Adenyla-5mp5'-adenosine monophosphateFosfato de adenosina

Database identifiers

CAS
136920-07-5、61-19-8
PubChem CID
6083
DTXSID
DTXSID5022560
ChEMBL
CHEMBL752
ChEBI
CHEBI:16027
UNII
415SHH325A
EC Number
200-500-0
Nikkaji
J4.814C

Properties

Computed structural propertiesFilling in

XLogP
-3.5
Topological polar surface area
186 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
11
Rotatable bonds
4
Heavy atoms
23
Formal charge
0
Complexity
481

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Cosmetics · 2 items

Cosmetic ingredients (Adenosine Phosphate) -> CIR (Cosmetic Ingredient Review)

Skin conditioning

SpringerMaterials PropertiesAngular frequency
LogP-3.1
Color/Form · 2 items

CRYSTALS FROM WATER + ACETONE

POWDER, NEEDLES FROM WATER & DIL ALC

Solubility · 5 items

ALMOST INSOL IN COLD H2O /YEAST ADENYLIC ACID MONO-HCL/

READILY SOL IN BOILING WATER

SOL IN 10% HCL

INSOL IN ALCOHOL

10 mg/mL at 20 °C

Melting Point · 2 items

196-200 °C

195 °C

Optical Rotation · 2 items

SPECIFIC OPTICAL ROTATION: -26 DEG @ 20 °C/D (C= 2, 10% HCL); & -47.5 DEG @ 20 °C/D (C= 2, 2% NAOH)

MAX ABSORPTION (WATER, PH= 1.1): 255 NM (LOG E= 4.16); SPECIFIC OPTICAL ROTATION: -41.78 DEG @ 50 °C/D (WATER)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 3 items

This chemical does not meet GHS hazard criteria for 97.7% (127 of 130) of all reports.

Not Classified

Aggregated GHS information provided per 130 reports by companies from 3 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information · 4 items

Chemical: 5'-Adenylic acid

REACH registered substance: Adenosine phosphate (EC: 200-500-0)

Acetamide, 2,2',2'',2'''-(1,2-ethanediyldinitrilo)tetrakis-, N,N,N',N',N'',N'',N''',N'''-octa-C12-18-alkyl derivs.: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

adenosine 5 monophosphate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - 5'-Adenylic acid: Environment tier I assessment
Hazard Classes and CategoriesNot Classified

Toxicology

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org
Natural Pollution SourcesNUCLEOTIDE; WIDELY DISTRIBUTED IN NATURE.
Human Toxicity Excerpts · 2 items

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP is used as a dietary supplement to boost immune activity, and is also used as a substitute sweetener to aid in the maintenance of a low-calorie diet.

Mechanism of Action · 1 item

Nucleotides such as Adenosine-5'-Monophosphate affect a number of immune functions, including the reversal of malnutrition and starvation-induced immunosuppression, the enhancement of T-cell maturation and function, the enhancement of natural killer cell activity, the improvement of delayed cutaneous hypersensitivity, helping resistance to such infectious agents as Staphylococcus aureus and Candida albicans, and finally the modulation of T-cell responses toward type 1 CD4 helper lymphocytes or Th1 cells. Studies have shown that mice fed a nucleotide-free diet have both impaired humoral and cellular immune responses. The addition of dietary nucleotides normalizes both types of responses. RNA, a delivery form of nucleotides, and ribonucleotides were used in these studies. The mechanism of the immune-enhancing activity of nucleic acids/nucleotides is not clear.

Absorption, Distribution and ExcretionAMP ADMIN TO RATS ORALLY WAS RECOVERED INTACT IN BLOOD. IT APPEARED RAPIDLY IN BLOOD (IN 15-30 MIN) & WAS ALSO RAPIDLY DISTRIBUTED, SINCE PLASMA CONCN WAS DECR BY FACTOR OF 5 IN 2 HR.
Tissue LocationsAll Tissues
Cellular LocationsCytoplasm
Metabolite Pathways2-Hydroxyglutric Aciduria (D And L Form)

Uses & manufacturing

Uses · 3 items

Related reactions

16 records
New reaction record
HRID 1959 reaction equation
HRID 1959As productuspto-grants-1998_03
HRID 363340 reaction equation
HRID 363340As reactantuspto-grants-1999_02
HRID 373662 reaction equation
HRID 373662As solventuspto-grants-1992_11
HRID 373663 reaction equation
HRID 373663As reactantuspto-grants-1992_11
HRID 897267 reaction equation
HRID 897267As productuspto-grants-2005_07
HRID 965471 reaction equation
HRID 965471As productuspto-grants-1998_06
HRID 1087709 reaction equation
HRID 1087709As reactantuspto-grants-1990_10
HRID 1288784 reaction equation
HRID 1288784As reactantuspto-grants-1998_05
Page 1 of 2

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
Physical DescriptionSolid
Stability/Shelf LifeFREE ACID & ITS SALTS ARE STABLE FOR LONG PERIODS IN DRY STATE; NEUTRAL SOLN ARE ALSO STABLE
Dissociation ConstantsPK1= 3.8; PK2= 6.2
Collision Cross Section · 6 items

167.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

167 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]

171.4 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

180.73 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

179.5 Ų [M+Na-2H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

171.5 Ų [M+H]+

Physicochemical properties

Melting point
87.8 °C · 87.800 °C (fusion)
storage temp.
20 °C · −20°C
WGK Germany
3 · 3
F
3 · 3-10-21

LOCAL ERYTHEMIA, SLIGHT FLUSHING, DIZZINESS, DIURESIS, & PALPITATION... ESPECIALLY WITH LARGE DOSES OF AQ SOLN. IN TREATMENT OF BURSITIS OR CHRONIC CALCIFIC TENDINITIS /DRUG OFTEN PRODUCES/ EXACERBATION OF SYMPTOMS AFTER 5TH TO 10TH DAY /ADVERSE EFFECT, IM (AS SODIUM SALT)/

DIARRHEA, DIZZINESS, & HEADACHE /SUBLINGUAL ADMIN/. ANAPHYLACTIC SHOCK... FOLLOWING USE OF GELATIN SOLN /IM ADMIN AS SODIUM SALT/. DYSPNEA & TIGHTNESS OF CHEST /ADVERSE EFFECT/

Non-Human Toxicity ExcerptsBIOSYNTHESIS OF FATTY ACIDS FROM [1-(14)C]-ACETATE BY CHICKEN LIVER SLICES IN VITRO WAS INHIBITED BY ADENOSINE-5'-MONOPHOSPHATE.

Safety data

F
3-10-21
wgk
3

CIR ingredient: Adenosine Phosphate

IN BIOCHEMICAL RESEARCH

MEDICATION

Methods of Manufacturing · 2 items

YEAST ADENYLIC ACID BY PRECIPITATION FROM YEAST NUCLEIC ACID. MUSCLE ADENYLIC ACID BY PRECIPITATION FROM TISSUES; BY HYDROLYSIS OF ATP WITH BARIUM HYDROXIDE...

COMMERCIAL PREPN BY ENZYMATIC PHOSPHORYLATION OF ADENOSINE. MONOGRAPH ON SYNTHESIS OF NUCLEOTIDES: CR PEFTIT, SYNTHETIC NUCLEOTIDES VOL 1 (VAN NOSTRAND-REINHOLD, NEW YORK, 1972) 252 PP.

Use ClassificationCosmetics -> Skin conditioning
General Manufacturing Information · 2 items

5'-Adenylic acid: ACTIVE

MONOPHOSPHORIC ESTER OF ADENOSINE, IE, NUCLEOTIDE CONTAINING ADENINE, D-RIBOSE & PHOSPHORIC ACID. ADENYLIC ACID IS CONSTITUENT OF MANY IMPORTANT COENZYMES.

Additional notes

DefinitionChEBI: 9-(5-O-Phosphonopentofuranosyl)-9H-purin-6-amine is a purine ribonucleoside monophosphate.